• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索大隐静脉移植物的体外潜能:内膜增生和再内皮化模型

Exploring the Potential of Saphenous Vein Grafts Ex Vivo: A Model for Intimal Hyperplasia and Re-Endothelialization.

作者信息

Haron Nur A'tiqah, Ishak Mohamad Fikeri, Yazid Muhammad Dain, Vijakumaran Ubashini, Ibrahim Roszita, Raja Sabudin Raja Zahratul Azma, Alauddin Hafiza, Md Ali Nur Ayub, Haron Hairulfaizi, Ismail Muhammad Ishamuddin, Abdul Rahman Mohd Ramzisham, Sulaiman Nadiah

机构信息

Centre for Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.

Department of Community Health, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.

出版信息

J Clin Med. 2024 Aug 14;13(16):4774. doi: 10.3390/jcm13164774.

DOI:10.3390/jcm13164774
PMID:39200916
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11355503/
Abstract

Coronary artery bypass grafting (CABG) utilizing saphenous vein grafts (SVGs) stands as a fundamental approach to surgically treating coronary artery disease. However, the long-term success of CABG is often compromised by the development of intimal hyperplasia (IH) and subsequent graft failure. Understanding the mechanisms underlying this pathophysiology is crucial for improving graft patency and patient outcomes. : This study aims to explore the potential of an ex vivo model utilizing SVG to investigate IH and re-endothelialization. : A thorough histological examination of 15 surplus SVG procured from CABG procedures at Hospital Canselor Tuanku Muhriz, Malaysia, was conducted to establish their baseline characteristics. : SVGs exhibited a mean diameter of 2.65 ± 0.93 mm with pre-existing IH averaging 0.42 ± 0.13 mm in thickness, alongside an observable lack of luminal endothelial cell lining. Analysis of extracellular matrix components, including collagen, elastin, and glycosaminoglycans, at baseline and after 7 days of ex vivo culture revealed no significant changes in collagen but demonstrated increased percentages of elastin and glycosaminoglycans. Despite unsuccessful attempts at re-endothelialization with blood outgrowth endothelial cells, the established ex vivo SVG IH model underscores the multifaceted nature of graft functionality and patency, characterized by IH presence, endothelial impairment, and extracellular matrix alterations post-CABG. : The optimized ex vivo IH model provides a valuable platform for delving into the underlying mechanisms of IH formation and re-endothelialization of SVG. Further refinements are warranted, yet this model holds promise for future research aimed at enhancing graft durability and outcomes for CAD patients undergoing CABG.

摘要

利用大隐静脉移植物(SVG)进行冠状动脉旁路移植术(CABG)是外科治疗冠状动脉疾病的一种基本方法。然而,CABG的长期成功常常受到内膜增生(IH)的发展及随后移植物失败的影响。了解这种病理生理学的潜在机制对于提高移植物通畅率和患者预后至关重要。:本研究旨在探索利用SVG的体外模型来研究IH和再内皮化的潜力。:对从马来西亚敦库穆赫里兹医院的CABG手术中获取的15条多余SVG进行了全面的组织学检查,以确定其基线特征。:SVG的平均直径为2.65±0.93毫米,预先存在的IH平均厚度为0.42±0.13毫米,同时可观察到管腔内缺乏内皮细胞内衬。对包括胶原蛋白、弹性蛋白和糖胺聚糖在内的细胞外基质成分在基线和体外培养7天后的分析显示,胶原蛋白无显著变化,但弹性蛋白和糖胺聚糖的百分比增加。尽管用血液衍生内皮细胞进行再内皮化的尝试未成功,但所建立的体外SVG IH模型强调了移植物功能和通畅性的多方面性质,其特征为CABG后存在IH、内皮损伤和细胞外基质改变。:优化后的体外IH模型为深入研究SVG的IH形成和再内皮化的潜在机制提供了一个有价值的平台。尽管仍需进一步完善,但该模型为未来旨在提高接受CABG的CAD患者移植物耐久性和预后的研究带来了希望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/5056aaf12818/jcm-13-04774-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/bb798963c193/jcm-13-04774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/c4e4f837772b/jcm-13-04774-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/97735a0c3353/jcm-13-04774-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/5056aaf12818/jcm-13-04774-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/bb798963c193/jcm-13-04774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/c4e4f837772b/jcm-13-04774-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/97735a0c3353/jcm-13-04774-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68a2/11355503/5056aaf12818/jcm-13-04774-g004.jpg

相似文献

1
Exploring the Potential of Saphenous Vein Grafts Ex Vivo: A Model for Intimal Hyperplasia and Re-Endothelialization.探索大隐静脉移植物的体外潜能:内膜增生和再内皮化模型
J Clin Med. 2024 Aug 14;13(16):4774. doi: 10.3390/jcm13164774.
2
Intimal hyperplasia, saphenous vein graft disease, and clinical outcomes: Insights from the CTSN VEST randomized trial.内膜增生、隐静脉移植物疾病和临床结局:来自 CTSN VEST 随机试验的见解。
J Thorac Cardiovasc Surg. 2024 May;167(5):1782-1792.e5. doi: 10.1016/j.jtcvs.2022.10.034. Epub 2022 Oct 30.
3
Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.冠状动脉旁路移植术后 1 年隐静脉移植物增生和闭塞的相关因素:来自 CASCADE 随机试验的分析。
Circulation. 2013 Sep 10;128(11 Suppl 1):S213-8. doi: 10.1161/CIRCULATIONAHA.112.000328.
4
Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.替格瑞洛联合标准阿司匹林对冠状动脉旁路移植术患者隐静脉桥通畅率的影响(POPular CABG):一项随机、双盲、安慰剂对照试验。
Circulation. 2020 Nov 10;142(19):1799-1807. doi: 10.1161/CIRCULATIONAHA.120.050749. Epub 2020 Aug 31.
5
One-year patency control and risk analysis of eSVS®-mesh-supported coronary saphenous vein grafts.eSVS® 网状支撑冠状动脉大隐静脉移植血管的一年通畅性控制及风险分析
J Cardiothorac Surg. 2015 Aug 8;10:108. doi: 10.1186/s13019-015-0293-y.
6
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial.冠状动脉旁路移植术中使用具有多个与单个远端靶目标的隐静脉移植物:来自经转染的体外静脉移植物工程(PREVENT)IV 试验的一年移植物失败和五年结果。
Circulation. 2011 Jul 19;124(3):280-8. doi: 10.1161/CIRCULATIONAHA.110.991299. Epub 2011 Jun 27.
7
External Stenting for Saphenous Vein Grafts in Coronary Surgery: A Systematic Review and Meta-Analysis.冠状动脉手术中隐静脉移植血管的体外支架置入:一项系统评价和荟萃分析。
J Clin Med. 2023 Nov 29;12(23):7395. doi: 10.3390/jcm12237395.
8
1-Year Patency of Biorestorative Polymeric Coronary Artery Bypass Grafts in an Ovine Model.生物修复性聚合物冠状动脉旁路移植术在羊模型中的1年通畅率
JACC Basic Transl Sci. 2022 Nov 9;8(1):19-34. doi: 10.1016/j.jacbts.2022.06.021. eCollection 2023 Jan.
9
A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting.冠状动脉旁路移植术中隐静脉移植物外部支架置入的随机试验
Ann Thorac Surg. 2015 Jun;99(6):2039-45. doi: 10.1016/j.athoracsur.2015.01.060. Epub 2015 Apr 15.
10
The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery.双抗血小板治疗(DAPT)评分与冠状动脉旁路移植术后大隐静脉桥通畅率的关系。
Acta Cardiol. 2021 Sep;76(7):785-791. doi: 10.1080/00015385.2021.1912248. Epub 2021 Apr 21.

引用本文的文献

1
Acute histopathological and biochemical changes in saphenous vein grafts during coronary artery bypass grafting: A closer look at mTOR signaling.冠状动脉搭桥术中隐静脉移植物的急性组织病理学和生化变化:深入研究mTOR信号通路
Turk Gogus Kalp Damar Cerrahisi Derg. 2025 Jul 21;33(3):279-287. doi: 10.5606/tgkdc.dergisi.2025.27697. eCollection 2025 Jul.

本文引用的文献

1
Generation of a novel model to study re-endothelialization.生成一种新型模型以研究再内皮化。
Artif Cells Nanomed Biotechnol. 2023 Dec;51(1):408-416. doi: 10.1080/21691401.2023.2245456.
2
Role of Matrix Metalloproteinase-2 in the Development of Atherosclerosis among Patients with Coronary Artery Disease.基质金属蛋白酶-2 在冠心病患者动脉粥样硬化发展中的作用。
Mediators Inflamm. 2023 Jul 7;2023:9715114. doi: 10.1155/2023/9715114. eCollection 2023.
3
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets.
内皮功能障碍与 eNOS 解偶联:潜在治疗靶点的分子机制。
Cell Mol Biol Lett. 2023 Mar 9;28(1):21. doi: 10.1186/s11658-023-00423-2.
4
Effects of Hydroxytyrosol in Endothelial Functioning: A Comprehensive Review.羟基酪醇对血管内皮功能的影响:全面综述。
Molecules. 2023 Feb 16;28(4):1861. doi: 10.3390/molecules28041861.
5
Vascular smooth muscle cells in intimal hyperplasia, an update.内膜增生中的血管平滑肌细胞,最新进展
Front Physiol. 2023 Jan 4;13:1081881. doi: 10.3389/fphys.2022.1081881. eCollection 2022.
6
The alasian alth and Welleing ssessmen (MyHEBAT) Study Protocol: An Initiation of a National Registry for Extended Cardiovascular Risk Evaluation in the Community.亚洲心脏与健康评估(MyHEBAT)研究方案:社区开展的全国心血管扩展风险评估登记研究。
Int J Environ Res Public Health. 2022 Sep 19;19(18):11789. doi: 10.3390/ijerph191811789.
7
Recent strategies for improving hemocompatibility and endothelialization of cardiovascular devices and inhibition of intimal hyperplasia.改善心血管装置血液相容性和内皮化以及抑制内膜增生的最新策略。
J Mater Chem B. 2022 May 25;10(20):3781-3792. doi: 10.1039/d2tb00478j.
8
Oxidative Stress-Induced Endothelial Dysfunction in Cardiovascular Diseases.氧化应激诱导的心血管疾病中的血管内皮功能障碍。
Front Biosci (Landmark Ed). 2022 Mar 18;27(3):105. doi: 10.31083/j.fbl2703105.
9
Extracellular Matrix in Aging Aorta.衰老主动脉中的细胞外基质
Front Cell Dev Biol. 2022 Feb 21;10:822561. doi: 10.3389/fcell.2022.822561. eCollection 2022.
10
PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle.血小板衍生生长因子调节血管平滑肌中环鸟苷酸合酶的表达和 cGMP 信号转导。
Commun Biol. 2022 Mar 3;5(1):197. doi: 10.1038/s42003-022-03140-2.